LOGIN
TEAM
CONTACT US
COLLECTIONS
Bladder
Breast
Leukemia
Liver
Sarcoma
HOME
You need to enable JavaScript to run this app page.
Breast
BCM-15030
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: BCM-15030
Patient Information
Clinical Timeline
Color Keys:
Positive
Negative
N/A
Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection
Model Information for Model: BCM-15030
Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)
Mutation data is currently not available.
CNV
Histology Information for Model: BCM-15030
Patient
PDX
ER
H&E
HER2
PR
Metastasis Information for Model: BCM-15030
Patient
PDX
Abdomen
Abdominal cavity
Adrenal Gland
Anterosuperior mediastinum
Ascites
Axillary Lymph Node
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Head
Hilar Node
Hip
Kidney
Leg bone
Leptomeninges
Liver
Lung
Lymph Node
Mediastinum
Metastasis Pleura
Neck
None
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural cavity
Pleural effusion
Posterior cervical nodes
Pulmonary
Retrocrural Lymph Node
SVC node
Sacral Spine
Skin
Spine
Spleen
Thymus
Patient Treatment Information for Model: BCM-15030
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
10
Fluorouracil, Doxorubicin, Cyclophosphamide
Adjuvant
34.42
34.75
120 days
Not Reported
Not Applicable
Treatment Completed
20
Other, Tamoxifen
Recurrent/Metastatic
43.59
48.76
1887 days
Not Reported
Not Applicable
Disease Progression
25
Goserelin, Anastrozole
Recurrent/Metastatic
49.09
49.18
33 days
Not Reported
Not Applicable
Side Effects
30
Megestrol acetate
Recurrent/Metastatic
49.26
55.52
2285 days
Not Reported
Not Applicable
Disease Progression
35
Fulvestrant
Recurrent/Metastatic
55.52
56.77
456 days
Not Reported
Not Applicable
Disease Progression
40
Letrozole
Recurrent/Metastatic
56.85
57.02
62 days
Not Reported
Not Applicable
Disease Progression
45
Tamoxifen
Recurrent/Metastatic
57.1
57.18
29 days
Not Reported
Not Applicable
Treatment Completed
50
Oophorectomy
Recurrent/Metastatic
57.18
57.18
Unknown
Not Reported
Not Applicable
Treatment Completed
55
Anastrozole
Recurrent/Metastatic
57.19
57.77
212 days
Not Reported
Not Applicable
Disease Progression
60
Everolimus, Exemestane
Recurrent/Metastatic
57.83
58.08
91 days
Not Reported
Not Applicable
Side Effects
65
Palbociclib, Letrozole
Recurrent/Metastatic
58.1
58.68
212 days
Not Reported
Not Applicable
Disease Progression
70
Radiation Therapy (RT)
Recurrent/Metastatic
58.68
58.81
47 days
Not Reported
Not Applicable
Treatment Completed
75
Anastrozole
Recurrent/Metastatic
58.77
59.52
274 days
Not Reported
Not Applicable
Disease Progression
80
Capecitabine
Recurrent/Metastatic
59.61
61.0
507 days
Not Reported
Not Applicable
Current Treatment
95
High-dose estrogen
Metastatic
60.9
61.0
37 days
Progressive Disease
Not Applicable
Disease Progression
Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.
Stay Connected